Search
Collegium Pharmaceutical Inc
COLLAdd to Watchlist
33.540USD
-0.140-0.42%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.09BMarket Cap
14.22P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Collegium Pharmaceutical Inc is 8.00, ranking 55 out of 157 in the Pharmaceuticals industry. The average price target is 48.00, with a high of 58.00 and a low of 44.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
54.333
Target Price
+62.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Collegium Pharmaceutical Inc
COLL
6
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Collegium Pharmaceutical Inc's expected revenue for the next quarter?
Collegium Pharmaceutical Inc's expected revenue is 201.05M.
What is Collegium Pharmaceutical Inc's price target?
Analysts forecast that Collegium Pharmaceutical Inc's price target is USD 48.00, with the highest forecast at USD 58.00 and the lowest forecast at USD 44.00.
How have Collegium Pharmaceutical IncCOLL's recent earnings per share performed?
The market expectation was USD 0.45, while Collegium Pharmaceutical IncCOLL's earnings per share (EPS) for the previous quarter was USD 0.54. EPS for the next quarter is expected at USD 1.72.
What is the analyst rating for Collegium Pharmaceutical Inc?
Based on the ratings of Collegium Pharmaceutical Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
